William Benton Jones - Net Worth and Insider Trading
William Benton Jones Net Worth
The estimated net worth of William Benton Jones is at least $804,233 dollars as of 2024-12-27. William Benton Jones is the See Remarks of Corvus Pharmaceuticals Inc and owns about 153,773 shares of Corvus Pharmaceuticals Inc (CRVS) stock worth over $804,233. Details can be seen in William Benton Jones's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William Benton Jones has not made any transactions after 2024-05-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William Benton Jones
William Benton Jones Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William Benton Jones owns 1 companies in total, including Corvus Pharmaceuticals Inc (CRVS) .
Click here to see the complete history of William Benton Jones’s form 4 insider trades.
Insider Ownership Summary of William Benton Jones
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRVS | Corvus Pharmaceuticals Inc | 2024-05-06 | See Remarks |
William Benton Jones Latest Holdings Summary
William Benton Jones currently owns a total of 1 stock. William Benton Jones owns 153,773 shares of Corvus Pharmaceuticals Inc (CRVS) as of May 6, 2024, with a value of $804,233.
Latest Holdings of William Benton Jones
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRVS | Corvus Pharmaceuticals Inc | 2024-05-06 | 153,773 | 5.23 | 804,233 |
Holding Weightings of William Benton Jones
William Benton Jones Form 4 Trading Tracker
According to the SEC Form 4 filings, William Benton Jones has made a total of 2 transactions in Corvus Pharmaceuticals Inc (CRVS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Corvus Pharmaceuticals Inc is the acquisition of 20,000 shares on May 6, 2024, which cost William Benton Jones around $34,600.
Insider Trading History of William Benton Jones
- 1
William Benton Jones Trading Performance
GuruFocus tracks the stock performance after each of William Benton Jones's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William Benton Jones is 22.45%. GuruFocus also compares William Benton Jones's trading performance to market benchmark return within the same time period. The performance of stocks bought by William Benton Jones within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William Benton Jones's insider trading performs compared to the benchmark.
Performance of William Benton Jones
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.99 | | | | | |
| Relative Return to S&P 500(%) | 7.36 | | | | | |
William Benton Jones Ownership Network
William Benton Jones Owned Company Details
What does Corvus Pharmaceuticals Inc do?
Who are the key executives at Corvus Pharmaceuticals Inc?
William Benton Jones is the See Remarks of Corvus Pharmaceuticals Inc. Other key executives at Corvus Pharmaceuticals Inc include director & President and CEO Miller Richard A Md , Chief Financial Officer Leiv Lea , and 10 percent owner Ecor1 Capital, Llc .
Corvus Pharmaceuticals Inc (CRVS) Insider Trades Summary
Over the past 18 months, William Benton Jones made 1 insider transaction in Corvus Pharmaceuticals Inc (CRVS) with a net purchase of 20,000. Other recent insider transactions involving Corvus Pharmaceuticals Inc (CRVS) include a net purchase of 577,634 shares made by Miller Richard A Md ,
In summary, during the past 3 months, insiders sold 0 shares of Corvus Pharmaceuticals Inc (CRVS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Corvus Pharmaceuticals Inc (CRVS) were sold and 597,634 shares were bought by its insiders, resulting in a net purchase of 597,634 shares.
Corvus Pharmaceuticals Inc (CRVS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Corvus Pharmaceuticals Inc Insider Transactions
William Benton Jones Mailing Address
Above is the net worth, insider trading, and ownership report for William Benton Jones. You might contact William Benton Jones via mailing address: 863 Mitten Road, Suite 102, Burlingame Ca 94010.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
